SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride-share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company was founded by Peter Beck in 2006 and is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is currently experiencing intense volatility as its stock price tests long-term technical support, driven by a broader sector-wide selloff and investor frustration with recent market performance. While many retail traders are debating whether to buy the dip or cut losses, sentiment is divided between those bracing for further downside and long-term believers betting that continued business execution and upcoming engine test milestones will provide a catalyst for recovery.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius Group is facing significant selling pressure amid broader market rotation and sentiment-driven volatility, despite recently securing a major compute agreement and unveiling an asset-light expansion model. The community remains deeply divided, with many investors viewing the current dip as a strategic opportunity to accumulate shares ahead of earnings, while others are bracing for further downside due to ongoing short interest and lingering concerns over data center regulation.

AST SpaceMobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an intellectual property and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is facing significant market pressure as investors react to a $1 billion convertible note offering, raising concerns about dilution and management's previous capital commitments. While many community members are venting frustration over the timing of this financing, others are highlighting the deal's favorable terms and long-term potential for accelerating satellite deployment and securing launch independence.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo is trending as investors weigh significant regulatory progress against ongoing frustration over missed operational targets, leading to high-volume debates between those anticipating a major short squeeze and those skeptical of the company's long-term commercialization timeline. The community remains deeply divided, focusing heavily on upcoming criticality milestones for the Groves reactor and the impact of continued insider share sales on the stock's performance.

Marvell Technology, Inc. engages in the design, development, and sale of integrated circuits. Its products include data processing units, security solutions, automotive, coherent DSP, DCI optical modules, ethernet controllers, ethernet PHYs, ethernet switches, linear driver, PAM DSP, transimpedance amplifiers, fibre channel, HDD, SSD controller, storage accelerators, ASIC, and Marvell government solutions. It operates through the following geographical segments: United States, Singapore, Israel, India, China, and Others. The company was founded by Wei Li Dai and Pantas Sutardja in 1995 and is headquartered in Wilmington, DE.

Marvell Technology Inc

Marvell Technology is experiencing significant volatility as investors rotate away from semiconductor stocks, fueled by broader market concerns and frustration over the stock's recent performance following high-profile industry hype. Community discourse is currently split between those panicking over the sharp correction and others aggressively scaling into positions, betting that the long-term AI infrastructure thesis remains intact despite the technical breakdown.

Atai Beckley, Inc. is a clinical-stage biopharmaceutical company focused on developing effective, rapid-acting, and convenient mental health treatments. The company is headquartered in New York, NY.

AtaiBeckley Inc.

ATAI is experiencing heightened volatility and intense investor interest following reports that Eli Lilly is in advanced talks to acquire the company at a significant premium. While shareholders are actively debating the merits of the deal versus the company's long-term pipeline potential, the market is pricing in the acquisition with considerable speculation over whether a bidding war will emerge.

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth Group is seeing increased investor optimism following a robust earnings report that beat consensus estimates and featured a raised full-year profit outlook. The community is actively discussing the stock's strong margin control and recovery, with many traders viewing the recent price action as a pivot toward long-term value despite ongoing sector-wide scrutiny.

Lucid Group, Inc. manufactures electric vehicles. It designs, develops, and builds energy storage systems for electric vehicles and supplies automakers with the battery pack system needed to power hybrid, plug-in, and electric vehicles. The company was founded in December 2007 and is headquartered in Newark, CA.

Lucid Group Inc

Lucid Group is experiencing extreme volatility and heavy retail attention following a sharp price swing triggered by reports of bankruptcy rumors, which the company categorically denied through an SEC filing and a cease-and-desist. The community is deeply divided, with bulls actively coordinating to trigger a short squeeze against a high borrow fee backdrop, while bears remain focused on long-term concerns regarding cash burn and liquidity.

Oracle Corporation. The Group's principal activities are to develop, manufacture, market, distribute and service computer software. It has two businesses, software and services, which are further divided into five segments. Its software business consist of two segments: The new software license segment is engaged in the licensing of database, middleware software and applications software.The software license updates and product support segment provides customers with rights to unspecified software product upgrades and maintenance releases, internet access to technical content, internet and telephone access to technical support personnel. Its services business is comprised of three segments: The consulting segment provides services in business strategy and analysis, business process simplification, solutions integration and the implementation, enhancement and upgrade of database, middleware and applications software. On Demand includes Oracle On Demand and Advanced Customer Services.

Oracle Corp.

Oracle is experiencing significant volatility as investors debate whether recent price declines represent a bottoming process or continued downside due to concerns over heavy AI-related debt and capital expenditure. The stock is currently seeing a tug-of-war between retail traders looking for a recovery based on major cloud contract rumors and institutional bears skeptical of the company's long-term reliance on AI infrastructure spending.

Taiwan Semiconductor Manufacturing Co., Ltd. engages in the manufacture and sale of integrated circuits and wafer semiconductor devices. Its chips are used in personal computers and peripheral products, information applications, wired and wireless communications systems products, and automotive and industrial equipment including consumer electronics such as smartphones, digital television, game consoles, and digital cameras. The company was founded by Chung Mou Chang on February 21, 1987 and is headquartered in Hsinchu, Taiwan.

Taiwan Semiconductor Manufacturing - ADR

TSMC is trending as its record-breaking revenue and massive June growth surge confirm that the demand for AI infrastructure and advanced semiconductors remains extremely strong. While the broader chip sector has faced recent volatility, the community is actively debating whether the stock's muted price reaction to these blowout fundamentals signals a healthy consolidation or an over-stretched valuation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

ARDX Stock Tumbles As Xphozah Loses Final Medicare Reimbursement Battle  

Equity

The U.S. Court of Appeals for the D.C. Circuit said federal law prevents judges from reviewing Medicare’s decision to include certain kidney drugs in the dialysis payment bundle.


Aquestive Therapeutics (AQST) Moves 6.6% Higher: Will This Strength Last?

Aquestive Therapeutics (AQST) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Ardelyx Stock Up 70%: What to Know About This $490,000 Insider Transaction

Key PointsAccording to an SEC filing, an executive at Ardelyx reported selling 81,898 directly held Common Stock shares on June 18, 2026, generating a transaction value of $490,000...

ARDX Edges Up After Hours On IBSRELA Momentum And Profitability ‘Right Around The Corner’

CFO said at a conference that profitability is “right around the corner,” though the company is waiting for more top-line certainty before formal guidance.


Should You Buy Ardelyx (ARDX)?

Ardelyx (NASDAQ:ARDX) Trading Up 7.4% - What's Next?

Ardelyx (NASDAQ:ARDX) Shares Up 7.4% - What's Next...

FY2030 Earnings Forecast for Ardelyx Issued By HC Wainwright

Ardelyx, Inc. (NASDAQ:ARDX - Free Report) - Research analysts at HC Wainwright cut their FY2030 earnings per share estimates for Ardelyx in a research note issued on Friday, May 1st. HC Wainwright analyst M. Caufield now anticipates that the biopharmaceutical company will earn $1.60 per share for th...

AIGH Capital Management LLC Purchases 951,500 Shares of Ardelyx, Inc. $ARDX

AIGH Capital Management LLC lifted its position in Ardelyx, Inc. (NASDAQ:ARDX - Free Report) by 479.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,150,000 shares of the biopharmaceutical company's...

Ardelyx (NASDAQ:ARDX) Shares Gap Down After Earnings Miss

Ardelyx (NASDAQ:ARDX) Shares Gap Down Following Weak Earnings...

Ardelyx (NASDAQ:ARDX) Posts Quarterly Earnings Results, Misses Expectations By $0.03 EPS

Ardelyx (NASDAQ:ARDX - Get Free Report) issued its quarterly earnings results on Thursday. The biopharmaceutical company reported ($0.15) earnings per share for the quarter, missing the consensus...

Ardelyx, Inc. is a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant unmet medical needs. Its products include IBSRELA and XPHOZAH. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet in October 2007 and is headquartered in Waltham, MA.

Ardelyx Inc

Bearish Sentiment

Memory - $MU, $SNDK, $STX, $SKHY, etc.

Neoclouds - $NBIS, $CRWV, $IREN, $APLD, etc.

Space - $RKLB, $SPCX, $ASTS, $VOYG, etc.

Neoclouds, space, and memory are among the market's most beaten-down sectors over the past week - all trading well off their recent highs despite strong underlying demand. Which are you most interested in buying right now? Explain your reasoning in the comments.

Which beaten-down industry are you most interested in adding exposure to?

Current Price	$5.15
Prev Close	$5.30
Open	$5.26
Dividend Yield	0.00%
50-Day Moving Average	$5.92
Beta	1.01
Avg. Volume	4.69M
PE Ratio	-22.25

52-Week High	$8.40
52-Week Low	$4.08
Market Capitalization	$1.31B
EPS (Annual)	-$0.2556
Price to Book	8.81
Revenue Per Employee	$832,965.23

Feed

News

Sentiment

Earnings

Fundamentals

Info

ARDXArdelyx Inc

Latest ARDX News